» Articles » PMID: 23599746

Expression of the PXR Gene in Various Types of Cancer and Drug Resistance

Overview
Journal Oncol Lett
Specialty Oncology
Date 2013 Apr 20
PMID 23599746
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnane X receptor (PXR) is a member of the nuclear receptor superfamily of ligand-regulated transcription factors. PXR is a key xenobiotic receptor that regulates the expression of genes implicated in drug metabolism, detoxification and clearance, including drug metabolizing enzymes and transporters, suggesting that it is significant in the drug resistance of cancer cells. PXR is expressed in a wide range of tissues in the human body. Studies have demonstrated that PXR is expressed in a variety of tumor types, correlating not only with drug resistance but also with the cell proliferation, apoptosis and prognosis of cancer. The purpose of the present review is to provide a comprehensive review of PXR and its potential roles in multidrug resistance and the biological characteristics of PXR-positive tumors.

Citing Articles

Evaluation of bioaccessibility, metabolic clearance and interaction with xenobiotic receptors (PXR and AhR) of cinnamaldehyde.

Husain I, Gurley B, Kothapalli H, Wang Y, Della Vedova L, Chittiboyina A Food Chem (Oxf). 2025; 10():100237.

PMID: 39845339 PMC: 11751564. DOI: 10.1016/j.fochms.2024.100237.


Bile Acids and Microbiota Interplay in Pancreatic Cancer.

Malhotra P, Palanisamy R, Caparros-Martin J, Falasca M Cancers (Basel). 2023; 15(14).

PMID: 37509236 PMC: 10377396. DOI: 10.3390/cancers15143573.


Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes.

Kiouri D, Ntallis C, Kelaidonis K, Peana M, Tsiodras S, Mavromoustakos T Proteomes. 2023; 11(2).

PMID: 37368467 PMC: 10305495. DOI: 10.3390/proteomes11020021.


Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us.

Kumar S, Sherman M Int J Mol Sci. 2023; 24(8).

PMID: 37108395 PMC: 10138578. DOI: 10.3390/ijms24087233.


Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers.

Zhang L, Ye B, Chen Z, Chen Z Acta Pharm Sin B. 2023; 13(3):982-997.

PMID: 36970215 PMC: 10031261. DOI: 10.1016/j.apsb.2022.10.002.


References
1.
Wentworth J, Agostini M, Love J, Schwabe J, Chatterjee V . St John's wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol. 2000; 166(3):R11-6. DOI: 10.1677/joe.0.166r011. View

2.
Zhou C, Poulton E, Grun F, Bammler T, Blumberg B, Thummel K . The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol. 2006; 71(1):220-9. DOI: 10.1124/mol.106.029264. View

3.
Ouyang N, Ke S, Eagleton N, Xie Y, Chen G, Laffins B . Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. Br J Cancer. 2010; 102(12):1753-61. PMC: 2883694. DOI: 10.1038/sj.bjc.6605677. View

4.
Zhang B, Cheng Q, Ou Z, Lee J, Xu M, Kochhar U . Pregnane X receptor as a therapeutic target to inhibit androgen activity. Endocrinology. 2010; 151(12):5721-9. PMC: 2999492. DOI: 10.1210/en.2010-0708. View

5.
Rosenfeld J, Vargas Jr R, Xie W, Evans R . Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol. 2003; 17(7):1268-82. DOI: 10.1210/me.2002-0421. View